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SARS-CoV-2 has tragically shown the cost of a global pandemic. Only a few years 
earlier, the outbreak of Zika virus in Brazil and elsewhere in South America caught the 
international community by surprise. There was no epidemiological surveillance for Zika 
virus established at the time, since the African-origin virus was previously endemic in Africa 
and Asia only; clinicians either failed to notify authorities of suspected cases, or reported 
Zika, dengue, and chikungunya infections in parallel, with limited diagnostic facilities 
available to differentiate between them.1 A lack of common understanding about diagnosis 
and symptoms produced different case definitions and a wide range of case estimates;2 early 
estimates of the risk of microcephaly varied across Brazil.3 These challenges delayed 
meaningful epidemiological interpretations and probably contributed to an increase in 
unsafe abortions4 and pregnancy delays5 throughout Latin America for fear of the Zika-
associated complications.  
Intensive global research established beyond doubt the association between 
maternal Zika virus infection and congenital malformations.6,7 However, we do not know if 
this association is unique to the Latin American outbreak and virus lineage, or whether 
similar symptoms occur elsewhere; and to what extent congenital malformations associated 
with Zika virus or other infections are present in Asia and Africa.  
In sub-Saharan Africa, surveillance data for both congenital malformations and 
laboratory diagnostics of Zika and related viruses are largely unavailable.8 Regardless, 
observed reintroduction of the Latin American outbreak lineage into Angola9 underscores a 
pressing question: what are, or will be, the spectrum of clinical manifestations of Zika virus 
infections in sub- Saharan Africa? Would we be able to detect a signal of Zika virus-induced 
decreased head circumference or even microcephaly? In Latin America, the standards 
produced by Estudio Colaborativo Latino Americano de Malformaciones Congenitas were 
instrumental to detect the signal of microcephaly at an early stage. Data from two African 
countries (Côte d’Ivoire and Cameroon) show a large variability in head circumference 
without the presence of Zika virus-induced microcephaly.10 
In addition, the origin of the Latin American Zika outbreak remains poorly understood 
and longer-term consequences of various vector-borne diseases, including chikungunya and 
dengue, on maternal health and child development are only partly understood.11,12  
To address gaps in knowledge, we need to improve our understanding of the 
epidemiology and aetiology of congenital malformations and develop better tools for 
diagnosis, management, and prevention of infection-related causes in sub-Saharan Africa.11  
We therefore call for greater and more comprehensive action in research, capacity 
building, and development of a public health approach to congenital abnormalities in sub-
Saharan Africa. Recent investments in surveillance and diagnostic capacity as part of the 
COVID-19 pandemic response could serve as a catalyst for greater attention on arboviruses 
as well.  
The immediate aim should be to provide decision makers with a baseline frequency 
of congenital abnormalities, which is granular enough to account for regional variability. This 
baseline includes the simple routine measurement of head circumference at birth, which 
would allow detection of microcephaly. Of equal importance is strengthening health system 
responses to children who are born with congenital abnormalities in sub-Saharan Africa to 
ensure that new knowledge on the public-health burden goes hand in hand with the 
development of services and interventions to improve health and wellbeing of parents and 
affected children.  
Beyond the immediate benefit of preparedness for potential Zika epidemics in sub-
Saharan Africa, such work is of great importance for achieving universal health coverage and 
improving maternal and child health. 
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